The Pharmacy and Poisons Board has recalled Sure Condoms ahead of the Christmas holidays.
In a statement on Wednesday, December 11, the board indicated that the lubricated condoms dotted Batch No. 2405055, did not comply with the required specifications.
Consequently, all pharmaceutical outlets, healthcare facilities, healthcare professionals, and members of the public have been directed to quarantine the product immediately.
Pharmacies have also been directed to stop the distribution, sale or issuance of the product immediately.
Also Read: KEMSA Announces Lucrative Condom Tender: How to Bid
Cause of Action Over the Sure Condoms
At the same time, healthcare facilities, healthcare professionals and Kenyans have been directed to return the product to their nearest healthcare facility or respective suppliers.
The Board encourages the public to report any suspected cases of sub-standard medicines or adverse drug reactions to the nearest healthcare facility or the Pharmacy and Poisons Board through the following channels:
Here is the full Statement:
The Pharmacy and Poisons Board (“the Board”) draws public attention to the recall of the substandard sure lubricated condoms dotted, Batch No. 2405055, Manufactured by Indus Medicare Private Limited.
The product samples did not comply with the specifications for the freedom from holes (conductivity) test performed.
In light of this, the Board advises all pharmaceutical outlets, healthcare facilities, healthcare professionals, and members of the public to immediately quarantine the product and STOP the further distribution, sale, issuance, or use of the affected product batch and return the product to their nearest healthcare facility or respective suppliers.
ADVERT
The Board encourages the public to report any suspected cases of sub-standard medicines or adverse drug reactions to the nearest healthcare facility or the Pharmacy and Poisons Board through the following channels:
Also Read: Police Discover Used Condoms and Underwear in Brewing Alcohol
Govt Orders Quarantine of Painkiller
Earlier, PPB ordered the quarantine of the painkiller drug Mefnac oral (Mefenamic Acid 50 Mg/5 MI).
Therefore, the Board advised all pharmaceutical outlets, healthcare facilities, healthcare professionals, and members of the public to immediately quarantine the product.
According to the board, the painkiller was suspected of contamination with Diethylene Glycol (DEG)/Ethylene Glycol (EG) at levels above acceptable limits.
“The Pharmacy and Poisons Board (“the Board”) informs the public of a Quarantine Order issued for Mefnac Oral Suspension (Mefenamic Acid 50 Mg/5 MI) Manufactured by Efroze Chemical Industries Pvt Ltd, Pakistan,” PPB said.
Follow our WhatsApp Channel and join our WhatsApp Group for real-time news updates.
